High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements
specificHigh-grade B-cell lymphoma characterized by the abnormal rearrangement of MYC gene, BCL2 gene, and BCL6 gene. Patients with this type of lymphoma usually respond poorly to standard treatments and have a poor prognosis.
30
Centers
1
Active Trials
—
Cancer Funding
Top Centers for High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements(30)
Ranked by research excellence score (trials · grants · publications). Methodology →
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →